Emerald Health Therapeutics, Inc. (EMHTF)

0.0313 -0.0024 (-7.12%) At close: 03:48PM EDT

Emerald Health Therapeutics, Inc.

666 Burrard Street
Suite 2500
Vancouver, BC V6C 2X8
Canada

https://emeraldhealth.ca

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Mohammed Jiwan	Chief Operating Officer	152.5k	N/A	N/A
Mr. Bernie Hertel	VP of Fin. and Communications	N/A	N/A	N/A
Ms. Rebecca Wong	Sr. VP of Quality & Regulatory Affairs	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Corporate Governance

Emerald Health Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.